TippingPoint Biosciences

TippingPoint Biosciences has developed a proprietary small molecule screening platform aimed at treating diseases related to dysfunctional DNA packaging (chromatin). The platform uses a novel method of condensate biology to overcome a major hurdle and effectively model chromatin behavior outside of the body, which unlo

Based based in United States, TippingPoint Biosciences works in cancer.

Profile

TippingPoint Biosciences has developed a proprietary small molecule screening platform aimed at treating diseases related to dysfunctional DNA packaging (chromatin). The platform uses a novel method of condensate biology to overcome a major hurdle and effectively model chromatin behavior outside of the body, which unlocks the ability to discover and screen drugs for chromatin-related diseases […]

As a business in cancer, TippingPoint Biosciences is listed here with the public details available about it.

United States is where the company is located.

Directory data places it at the SOSV portfolio company stage.

Its team size is recorded as 2-10 employees.

Website: tippingpointbiosciences.com